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Abstract
Background: To investigate the relationship between depression and overactive bladder (OAB)/urinary incontinence
symptoms among the clinical OAB population.
Methods: Patients who were diagnosed with overactive bladder (OAB) and age-matched control subjects without
OAB were enrolled. Depression symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS-D).
OAB/incontinence symptoms were assessed using the validated questionnaires: ICIQ-UI, ICIQ-OAB, UDI-6, IIQ-7,
and OAB-q.
Results: 27.5 % of OAB patients in our study had depression (HADS ≥8), and 12 % of OAB patients had moderate to
severe depression (HADS-D ≥11). OAB patients reported significantly higher HADS-D depression scores compared
to age-matched controls (5.3 ± 3.9 versus 2.8 ± 3.9, p = 0.004). OAB patients with depression reported more severe
incontinence symptoms (ICIQ-UI), greater bother and more impact on quality of life (UDI-6, IIQ-7) compared to OAB
patients without depression (p = 0.001, 0.01, <0.001, respectively). However there were no differences in ICIQ-OAB and
OAB-q. Among OAB patients, there were positive correlations between the severity of depression symptoms and OAB/
incontinence symptoms (p-values <0.001 to 0.035).
Conclusions: 27.5 % of OAB patients have depression. OAB patients with depression reported more severe urinary
incontinence symptoms, greater bother and more impact on quality of life compared to those without depression.
Future studies are needed to further examine the mechanistic links between depression and OAB/urinary incontinence.
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Background
Overactive bladder (OAB) affects up to 1 in 6 adult men
and women in the United States [1]. The syndrome is
characterized by urinary urgency, with or without
urgency incontinence, usually with frequency and noc-
turia, in the absence of infection or other identifiable
causes [2]. Given the symptom bother and impact on
quality of life, it is anticipated that many OAB patients
would have psychosocial difficulties. A recent review
suggested that depression might be associated with OAB
[3]. However most of the published studies were
population-based epidemiological surveys. Surprisingly
there was been very few papers that focused on OAB pa-
tients who presented to clinics [4–8].
Chiara et al. [6] compared the depression scores be-
tween female patients with stress incontinence, urgency
incontinence, and mixed incontinence, and showed no dif-
ferences in the depression scores between the three
groups. In contrast, Stach-Lempinen et al. [7] showed that
the odds of depression was significantly higher in female
patients with urgency incontinence compared to those
with stress incontinence (OR 3.7, 95 % CI 1.30-10.49,
p = 0.026). Melville et al. [4] also showed that the odds of
depression was higher in female patients with urgency
incontinence or mixed incontinence compared to stress
incontinence (OR 9.2-11.5). None of the studies above re-
cruited a control group. In the only paper that recruited a
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control group, Zorn et al. [8] showed that patients with
idiopathic urgency incontinence reported higher depres-
sion scores than controls who did not have incontinence.
Overall the results of the studies were inconclusive.
A few studies have compared urinary incontinence
(UI) patients with depression versus UI patients without
depression. Melville et al. [4] showed that there was no
difference in the daily UI episodes or the percent with
moderate/large UI between UI patients with depression
versus those without depression. Sung et al. [5] studied
female obese UI patients, and also showed that there
was no difference in the numbers of urgency incontin-
ence episodes between obese UI patients with depression
versus obese UI patients without depression. However,
two other studies have reported higher Urogenital
Distress Inventory (UDI) scores among UI patients with
depression [4, 5].
It is evident that the few publications that have studied
the clinical UI population yielded conflicting results [4–8].
All of the studies have recruited patients with a myriad of
UI symptoms (stress, urgency, and mixed incontinence) or
causes (idiopathic, obstructive, and neurogenic incontin-
ence), thus the relationship between depression and OAB
may be confounded. Most studies have examined urinary
incontinence (UI) in general but have not focused on
OAB specifically. To our knowledge none of the studies
have specifically recruited OAB patients, compared OAB
patients with versus without depression, and have corre-
lated the severity of their depression and OAB symptoms.
Here we address the gap in the literature by specifically
investigating the relationship between depression and
OAB in the clinical OAB population. We have: (1) re-
cruited OAB patients and age-matched controls, (2) com-
pared their depression symptoms, (3) compared OAB
patients with versus without depression, and (4) per-
formed correlation analyses between the severity of their
depression and OAB/incontinence symptoms.
Methods
Subjects
Between October 2012 and July 2014, adult patients,
aged 18 or above, diagnosed with OAB and age-
matched controls without OAB were recruited into
this study that inquired their depression and urinary
symptoms. For OAB, patients must complain of urin-
ary urgency, with or without urgency incontinence,
usually with frequency and nocturia, in the absence
of infection or other identifiable causes, in accordance
with the 2002 ICS (International Continence Society)
definition of OAB [2]. The clinical evaluation was
performed by one clinician (HL) and followed the
published AUA guidelines [9]. Subjects with a history
of urinary incontinence surgery, prostate surgery, urethral
stricture disease, neurogenic bladder, urinary retention,
pelvic radiation, tuberculosis cystitis, cyclophosphamide
cystitis, genitourinary cancer, urinary stones, a docu-
mented positive urine culture in the past 6 weeks, or a
post-void residual volume ≥150 mL were not eligible.
Controls were recruited by local advertisement and re-
search database. Controls must have no prior diagnosis of
OAB or interstitial cystitis/bladder pain syndrome, no sig-
nificant lower urinary tract symptoms (AUA symptom
index < 7), no bladder or pelvic pain, and no evidence of
urinary infection. Controls were age-matched to the OAB
cohort. Age matching was operationalized by recruiting
similar percentages of patients and controls in the following
age bins: <35, 35–49, and ≥50 years old. All subjects signed
an informed consent. The Washington University School of
Medicine Institutional Review Board approved this study.
Assessment
Depression symptoms were assessed using the Hospital
Anxiety and Depression Scale (HADS) [10]. The ques-
tionnaire contains 7 items to assess depression symp-
toms (HADS-D) and 7 items to assess anxiety symptoms
(HADS-A). A score of ≥8 on the HADS-D was used to
operationalize the presence of depression [11]. We have
also used a cut-offs of HADS-D 8–10 to indicate mild
depression and ≥11 for moderate/severe depression. The
developers of the HADS have recommended these cut-
off points for mild (8–10), moderate (11–14), and severe
(15–21) depression [10, 11]. To quantify the severity of
depression symptoms, we have analyzed the HADS-D
data as a continuous variable.
OAB/incontinence symptoms were assessed using the
following validated questionnaires: 1) International Con-
sultation on Incontinence – Urinary Incontinence Short
Form (ICIQ-UI) [12], 2) International Consultation on
Incontinence – Overactive Bladder (ICIQ-OAB) [13], 3)
OAB-q Short Form [14], 4) Urogenital Distress Inventory
Short Form (UDI-6) [15], and 5) Incontinence Impact
Questionnaire Short Form (IIQ-7) [15]. Briefly, ICIQ-UI is
a 4-item questionnaire that assesses the frequency, amount
and interference of urinary incontinence. ICIQ-OAB is a 4-
item questionnaire that inquires about daytime frequency,
nighttime frequency, urgency, and urgency incontinence.
OAB-q contains two sub-scales that assess symptom bother
and condition-specific quality of life. UDI-6 and IIQ-7
measure urinary distress and incontinence impact.
Statistical analysis
Linear regression models (continuous variables) were used
for multivariate comparisons between OAB and controls,
and between the OAB subgroups (with versus without de-
pression), adjusting for age (continuous variable) and sex.
Other potential covariates were not included in the
models due to the given sample size. Spearman’s correl-
ation was used for correlation analyses. p < 0.05 was
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considered significant difference. Data were presented as
mean ± SD in the tables. All statistical analysis was com-
pleted using the open source statistical package R v3.2.0.
Results
Study population
Fifty-one adult OAB patients and 30 age-matched con-
trols participated in this study. Appendix 1 described the
study population (demographics, urinary symptoms,
validated questionnaires, and medical comorbidities).
The mean age (± SD) of the OAB and the control
groups was 53.8 ± 11.9 and 54.2 ± 12.3, respectively.
There was no significant age or sex difference between
the two groups (p = 0.984 and 0.14). As expected, OAB
patients had worse OAB/incontinence symptoms and
quality of life compared to controls.
Depression symptoms among OAB patients, and
comparison to controls
OAB patients reported significantly higher depression
scores than controls on the HADS-D (5.3 ± 3.9 versus
2.8 ± 3.9, p = 0.004, Table 1). The HADS-D scores were
almost 90 % higher in OAB patients compared to con-
trols. Looking at the individual items on the HADS-D
scale, OAB patients fared worse compared to controls
on the following items: “I still enjoy the things I used to
enjoy;” “I can laugh and see the funny side of things;” “I
feel as if I am slowed down;” and “I look forward to
enjoyment to things.” (p = 0.044, 0.025, <0.001, 0.03, re-
spectively). 27.5 % of OAB patients reported a HADS-D
score ≥8, a threshold commonly used to indicate clinic-
ally relevant depression symptoms. 11.8 % OAB patients
reported a HADS-D score ≥11, indicating moderate to
severe depression symptoms. 32 % of OAB patients re-
ported a medical history of depression.
Comparison of OAB patients with versus without
depression symptoms
The OAB patients were categorized into two subgroups:
those with depression (HADS-D score ≥8, 27.5 %) versus
those without depression (HADS-D <8, 72.5 %). Their
OAB/incontinence symptoms and quality of life were then
compared between the two OAB subgroups. As shown in
Table 2, OAB patients with depression reported more se-
vere incontinence symptoms (ICIQ-UI), greater bother and
more impact on quality of life (UDI-6, IIQ-7) compared to
OAB patients without depression (p = 0.001, 0.01, <0.001,
respectively). However there were no differences in ICIQ-
OAB and OAB-q. The box plots of their ICIQ-UI, UDI-6
and IIQ-7 scores were presented in Fig. 1.
Since most of the validated urinary questionnaires
assess multiple urinary symptoms and presented the re-
sults as composite scores, we performed an exploratory
analysis to compare the difference in individual urinary
symptoms between OAB patients with and without
depression (Table 3). The results suggested that that
depression was correlated with urinary incontinence or
urgency incontinence symptoms (ICIQ-UI questions 3,
4, and ICIQ-OAB question 6a). However, the differences
in urgency, frequency, and nocturia symptoms did not
meet criteria for significance (p > 0.05).
Correlation between the severity of depression symptoms
and OAB/incontinence symptoms
To quantify the severity of depression symptoms, we have
analyzed the HADS-D data as a continuous variable (0 to
21). We then performed Spearman’s correlation analyses
between HADS-D and the urinary questionnaires (Table 4).
Among OAB patients, there were positive correlations be-
tween the severity of depression symptoms (HADS-D) and
the severity of OAB/incontinence symptoms, symptom
bother and impact on quality of life (ICIQ-UI, ICIQ-OAB,
UDI-6, IIQ-7, OAB-q, p-values <0.001 to 0.035). The high-
est correlations were between HADS-D and IIQ-7, and be-
tween HADS-D and OAB-q quality of life (correlation
coefficient = 0.53 and 0.40 respectively, p-values <0.001
and = 0.001 respectively).
Discussion
The present study specifically recruited OAB patients.
We compared the depression symptoms between OAB
and controls, and the urinary symptoms between the
two OAB subgroups – with and without depression. The
results showed that: (1) OAB patients have higher
depression scores than controls; (2) OAB patients with
depression reported more severe incontinence, greater
bother and more impact on quality of life than OAB
patients without depression; (3) there are positive corre-
lations between the severity of depression symptoms and
OAB/incontinence symptoms among the OAB patients.
27.5 % of OAB patients in our study have depression
symptoms based on the HADS-D scale (HADS-D ≥8).
Moreover, more than 10 % of OAB patients in our study
have moderate to severe depression (HADS-D ≥11). The
high prevalence of depression in the clinical OAB popu-
lation has therapeutic implications. Behaviors associated
with depression may impede response to clinical inter-
vention. For example, behavioral therapies for OAB (e.g.,
bladder training, dietary and fluid modification, pelvic
floor muscle exercises) require active participation of the
patient. Depressed patients may lack the self-motivation,
desire, and persistent effort necessary to have a success-
ful outcome with behavioral therapies. Depression may
also influence compliance to pharmacological therapies.
Since the goals of OAB treatment are not only to improve
symptoms but also to improve quality of life and function,
not recognizing depression and its impact may contribute
to suboptimal improvement in patient’s global impression
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of improvement (PGI-I). Urologists or urogynecologists
are usually not trained to diagnose and treat clinical
depression. However, they can screen OAB patients,
particularly those with severe urinary incontinence, for
depressive symptoms using the HADS-D scale. HADS-D
takes less than a minute for patients to complete. OAB pa-
tients that are flagged for depressive symptoms might be
considered for referral. It is important to recognize
Table 1 Comparison of depression symptoms between OAB






for age and sex)
HADS-D composite scores:
(mean ± SD)
5.3 ± 3.9 2.8 ± 3.9 0.004*
Individual items on the
HADS-D scale: (higher
score is worse)
I still enjoy the things
I used to enjoy:
0.88 ± 0.86 0.47 ± 0.90 0.044*
0 = definite as much
1 = not quite so much
2 = only a little
3 = hardly at all
I can laugh and see the
funny side of things:
0.45 ± 0.58 0.17 ± 0.46 0.025*
0 = as much as I
always could
1 = not quite so
much now
2 = definite not so
much now
3 = not at all
I feel cheerful: 0.59 ± 0.64 0.43 ± 0.73 0.21
3 = not at all
2 = not often
1 = sometimes
0 =most of the time
I feel as if I am slowed
down:
1.4 ± 0.90 0.55 ± 0.57 <0.001*
3 = nearly all the time
2 = very often
1 = sometimes
0 = not at all
I have lost interest in
my appearance:
0.76 ± 0.91 0.57 ± 0.86 0.16
3 = definitely
2 = I don’t take as much
care as I should
1 = I may not take quite
as much care
0 = I take just as much
care as ever
I look forward with
enjoyment to things:
0.75 ± 087 0.33 ± 0.66 0.03*
0 = as much as I
ever did
1 = rather less than I
used to
2 = definitely less than I
used to
3 = hardly at all
Table 1 Comparison of depression symptoms between OAB
and controls (adjusted for age and sex), *p < 0.05 (Continued)
I can enjoy a good book
or radio or Tv program:
0.41 ± 0.67 0.23 ± 0.63 0.22
0 = often
1 = sometimes
2 = not often
3 = very seldom
% with a HADS-D score
≥8 (presence of
depression):
27.5 % 13.8 % 0.158
% with a HADS-D score
≥11 (moderate to severe
depression):
11.8 % 10.3 % 0.744
% with medical history
of depression:
32 % 17 % 0.196
aOne control did not provide complete HADS-D data and was thus excluded
from comparisons
Table 2 Comparison of OAB/incontinence symptoms and
quality of life between OAB patients with depression versus













No. of subjects 14 (27.5 %) 37 (72.5 %)
Age (mean ± SD) 56.2 ± 9.9 52.8 ± 12.6 0.44
Sex (% females) 64 % 76 % 0.42
HADS-D scores 10.4 ± 2.4 3.3 ± 2.2 <0.001*
Validated questionnaires: (mean ± SD)
ICIQ-UI (urinary
incontinence, 0-21)
15.4 ± 4.7 10.8 ± 4.3 0.001*
UDI-6 (Urogenital Distress
Inventory, 0-24)




15.9 ± 8.7 6.1 ± 6.2 <0.001*
ICIQ-OAB (overactive
bladder, 0-16)
10.1 ± 3.2 9.0 ± 2.4 0.12
OAB-q symptom
bother subscale (6-36)
19.7 ± 7.9 18.9 ± 6.1 0.51
OAB-q quality of life
subscale (13-78)
36.6 ± 19.1 26.7 ± 15.2 0.074
*Statistically significant factors using multivariate logistic regression model
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psychosocial comorbidities in patients seeking care
because of their potential influence on therapeutics and
high prevalence (~30 % of OAB patients have depression,
and >10 % have moderate to severe depression).
We have demonstrated the positive associations between
the severity of depression symptoms and OAB/incontin-
ence symptoms in this cross-sectional study. However, to
the best of our knowledge, the nature behind this associ-
ation is unknown. It is unclear which came first, the
“chicken” or the “egg.” While it is not hard to imagine that
the symptoms and functional impairment associated with
OAB/incontinence may lead to depression, the possibility
that OAB and depression may share a common patho-
physiological pathway in some patients deserves further re-
search. Selective serotonin uptake inhibitors are commonly
used to manage depression. Reduction of serotonin levels
in the central nervous system is associated with increased
urinary frequency and bladder contractions, while activa-
tion of the central serotonergic system with a 5-HT uptake
inhibitor depresses bladder contractions and increases the
micturition threshold volume in animal studies [16]. Thus
depression may be mechanistically linked to OAB via the
serotonergic pathway. In an earlier clinical study,
duloxetine – a serotonin noradrenergic uptake inhibitor –
has been shown to improve both the “wet” and “dry” symp-
toms in OAB patients [17].
A few population-based cohort studies have tried to clar-
ify the relationship between depression and OAB. In an
one-year longitudinal study of women aged 40 years and
over, incident cases of depression was predicted by the
presence of urgency incontinence at baseline; while incident
cases of urgency incontinence was not predicted by depres-
sion at baseline [18]. In two longitudinal studies involving
older patients aged 65 and above, depression at baseline
predicted new onset urgency incontinence at the 1-year fol-
low up in one study and at the 6-year follow up in the sec-
ond study [19, 20]. Studies in the clinical OAB population
showed that depression improved with successful treatment
of OAB with anticholinergic medications, botulinum toxin
A, and InterStim neuromodulation [21–23]. Collectively
these studies suggested a causality relationship between de-
pression and OAB/incontinence. Future studies are needed
to further examine the mechanistic links between depres-
sion and OAB.
It is interesting to note that in Table 2, we demonstrated
differences in ICIQ-UI, UDI-6 and IIQ-7 but not in ICIQ-
OAB or OAB-q between OAB patients with and without
depression. As shown in Table 3, the main difference be-
tween OAB patients with and without depression was due
to their incontinence rather than their urgency or fre-
quency symptoms. Thus questionnaires that focus more
on the incontinence symptoms (ICIQ-UI, UDI-6 or IIQ-7)
captured the differences while questionnaires that focus
more on urgency/frequency symptoms (OAB-q or ICIQ-
OAB) may not have captured a difference.
The current study has limitations: 1) It was a single-
institution study with small sample size, thus it may not
have sufficient power for more detailed analyses (e.g.,
Fig. 1 OAB patients with anxiety had higher incontinence scores
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adjusting for additional potential covariates such as med-
ical comorbidities in the multivariate analysis); 2) findings
from patients seeking care at a tertiary medical center
because of the severity of their symptoms may not be
generalizable to the general OAB population; and 3)
assessment of depression was based on self-reported
symptoms. Although the HADS-D is commonly used to
screen for depression in the outpatient setting, it is not a
diagnostic tool for clinical depression, and it cannot be
ascertained without psychiatric evaluation which was not
performed here. Despite these limitations, many of the
comparisons clearly demonstrated differences. Large
multi-institutional studies of the clinical OAB population
are needed to further examine these relationships.
Conclusions
About 30 % of OAB patients have depression. OAB
patients with depression reported more severe urinary
incontinence symptoms, greater bother and more impact
on quality of life compared to those without depression.
Future studies are needed to further examine the
mechanistic links between depression and OAB/urinary
incontinence.
Table 4 Spearman’s correlation analyses between the severity
of depression symptoms (HADS-D from 0 to 21) and OAB/

























OAB-q quality of life
subscale (13-78)
0.40 0.001*
*Statistically significant factors using multivariate logistic regression model
Table 3 Comparison of individual urinary symptoms (adjusted for age and sex), *p < 0.05
OAB patients
with depression
(HADS-D ≥8), n = 14
OAB patients
without depression
(HADS-D <8), n = 37
p-value (adjusted
for age and sex)
Source of question
Incontinence symptoms:
How often do you leak urine?a 4.1 ± 1.1 2.8 ± 1.3 0.002* ICIQ-UI question 3
How much urine do you usually leak?b 3.7 ± 1.7 2.4 ± 1.2 0.002* ICIQ-UI question 4
Does urine leak before you can get to
the toilet?c (urgency incontinence)
2.8 ± 0.9 2.0 ± 0.8 0.003* ICIQ-OAB question 6a
Frequency or nocturia symptoms:
How many times do you urinate during the
day? (see footnote)d
1.7 ± 1.3 1.8 ± 1.2 0.98 ICIQ-OAB question 3a
During the night, how many times do you
have to get up to urinate, on average?e
2.6 ± 1.2 2.6 ± 1.1 0.93 ICIQ-OAB question 4a
Numeric rating scale of frequency (0-10) 6.4 ± 3.3 6.4 ± 2.3 0.86 0-10 numeric rating scale
Urgency symptoms:
Do you have to rush to the toilet to
urinate?f
2.9 ± 0.8 2.6 ± 0.9 0.10 ICIQ-OAB question 5a
Numeric rating scale of urgency (0-10) 6.9 ± 2.9 5.9 ± 2.4 0.18 0-10 numeric rating scale
USS (urgency severity scale, 0-3)g 2.1 ± 0.9 2.1 ± 0.7 0.83 USS is a 4-point self-reported rating scale
of the degree of urgency sensation
(none, mild, moderate, severe).g
*Statistically significant factors using multivariate logistic regression model
Based on the categories of response on the ICIQ questionnaire
aHow often do you leak urine? 0 = never, 1 = about once a week or less often, 2 = two or three times a week, 3 = about once a day, 4 = several times a day, 5 = all
the time
bHow much urine do you usually leak? 0 = none, 2 = a small amount, 4 = a moderate amount, 6 = a large amount
cDoes urine leak before you can get to the toilet? 0 = never, 1 = occasionally, 2 = sometimes, 3 =most of the time, 4 = all of the time
dHow many times do you urinate during the day? 0 = 1 to 6 times, 1 = 7 to 8 times 2 = 9 to 10 times, 3 = 11 to 12 times, 4 = 13 or more times
eDuring the night, how many times do you have to get up to urinate, on average? 0 = none, 1 = one time, 2 = two times, 3 = three times, 4 = four or more times
fDo you have to rush to the toilet to urinate? 0 = never, 1 = occasionally, 2 = sometimes, 3 =most of the time, 4 = all of the time
gUrgency severity scale (USS) reference: Nixon, A., Colman, S., Sabounjian, L. et al.: A validated patient reported measure of urinary urgency severity in overactive
bladder for use in clinical trials. J Urol, 174: 604, 2005
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Appendix 1
Abbreviations
HADS-D: Hospital anxiety and depression scale – depression subscale;
ICIQ-OAB: International consultation on incontinence – overactive bladder;
ICIQ-UI: International consultation on incontinence – urinary incontinence
short form; IIQ-7: Incontinence impact questionnaire short form;
OAB: Overactive bladder; UDI-6: Urogenital Distress Inventory Short Form;
UI: Urinary incontinence
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Table 5 Description of the study population
OAB patients Controls p-value (adjusted for age and sex)
Demographics:
No. of subjects 51 30
Age (mean ± SD) 53.8 ± 11.9 54.2 ± 12.3 0.98
Sex (% females) 73 % 57 % 0.14
Race (% white) 43.1 % 63.3 % 0.08
Age of diagnosis of OAB (mean ± SD) 47.5 ± 15.2 Not applicable
% with OAB symptoms less than one year? 24 % Not applicable
Urinary symptoms: (mean ± SD)
No. of daytime void (see footnote)a 1.8 ± 1.3 0.2 ± 0.6 <0.001
No of nighttime voidb 2.6 ± 1.1 0.9 ± 0.7 <0.001
How often rush to bathroom to void?c 2.7 ± 0.9 0.6 ± 0.7 <0.001
How often does urine leak before getting to the bathroom?d 2.2 ± 0.9 0.3 ± 0.5 <0.001
Validated questionnaires: (mean ± SD)
ICIQ-UI (urinary incontinence, 0–21) 12.0 ± 4.9 1.4 ± 2.0 <0.001
ICIQ-OAB (overactive bladder, 0–16) 9.3 ± 2.6 2.0 ± 1.5 <0.001
OAB-q symptom bother subscale (6–36) 19.1 ± 6.6 2.2 ± 2.8 <0.001
OAB-q quality of life subscale (13–78) 29.7 ± 16.9 2.0 ± 3.0 <0.001
UDI-6 (urogenital distress inventory, 0–24) 12.6 ± 5.6 0.9 ± 1.4 <0.001
IIQ-7 (incontinence impact questionnaire, 0–28) 8.8 ± 8.2 0.1 ± 0.4 <0.001
Medical comorbidities:
Hypertension 37 % 33 % 0.72
Diabetes 8 % 3 % 0.31
Stroke, transient ischemic attack 8 % 7 % 0.15
MI, angina 0 % 0 % 1.00
Based on the categories of response on the ICIQ-OAB questionnaire
aHow many times do you urinate during the day? 0 = 1 to 6 times, 1 = 7 to 8 times, 2 = 9 to 10 times, 3 = 11 to 12 times, 4 = 13 or more times
bDuring the night, how many times do you have to get up to urinate, on average? 0 = none, 1 = one time, 2 = two times, 3 = three times, 4 = four or more times
cDo you have to rush to the toilet to urinate? 0 = never, 1 = occasionally, 2 = sometimes, 3 =most of the time, 4 = all of the time
dDoes urine leak before you can get to the toilet? 0 = never, 1 = occasionally, 2 = sometimes, 3 =most of the time, 4 = all of the time
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